News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Conference News ESC 2019 GARFIELD-AF Analysis Digs Into Impact of Bleeding in Newly Diagnosed A-fib Todd Neale September 12, 2019
News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019
News Conference News ESC 2019 LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17 Todd Neale September 10, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
News Conference News EHRA 2019 Thromboembolic Risks High in Patients With A-fib, Valvular Disease Todd Neale March 25, 2019
News Conference News ACC 2019 Apple Watch May Detect A-fib in the General Population, but at What Cost? Yael L. Maxwell March 16, 2019